Clinical Trials on Exudative Age Related Macular Degeneration in Netherlands
Total 173 results
-
University Medical Center GroningenRecruiting
-
Erasmus Medical CenterCORR foundationActive, not recruitingAge-Related Macular DegenerationNetherlands
-
Maastricht University Medical CenterCognis Deutschland GmbH & Co. KGCompletedAge-Related Macular DegenerationNetherlands, United Kingdom
-
Maastricht University Medical CenterNewtriciousCompletedAge Related Macular DegenerationNetherlands
-
Newtricious R&D BVSprim Advanced Life SciencesCompletedAge-related Macular Degeneration (AMD)United States, Germany, Netherlands, United Kingdom
-
Maastricht University Medical CenterSenterNovem; Newtricious BV; Globus Ei BVCompleted
-
Frank G. HolzRadboud University Medical Center; Bayer; Hoffmann-La Roche; Novartis Pharmaceuticals and other collaboratorsActive, not recruitingAge Related Macular Degeneration (AMD)Germany, Italy, Netherlands, United Kingdom, France, Portugal, Denmark
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Austria, Belgium, Denmark, Switzerland, France, Netherlands, Portugal, Sweden, Norway
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Turkey, Austria, Canada, Czechia, United Kingdom, Hungary, Italy, Lithuania, Guatemala, France, Ireland, Argentina, Portugal, Spain, Sweden, Greece, Switzerland, Slovakia, Finland, Netherlands, Colombia, Mexico, Panama
-
Opthea LimitedActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Brazil, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Philippines and more
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationUnited States, Czechia, Italy, Taiwan, Australia, Israel, Belgium, France, Spain, Germany, Korea, Republic of, Portugal, Sweden, Netherlands, Malaysia, Switzerland
-
Association for Innovation and Biomedical Research...European Vision Institute Clinical Research NetworkActive, not recruitingAtrophy | Age Related Macular Degeneration | Prediction | Intermediate AMDPortugal, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedNeovascular (Wet) Age-related Macular DegenerationGermany, Switzerland, Netherlands
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsActive, not recruitingDry Age-related Macular DegenerationUnited States, Germany, United Kingdom, Spain, Poland, Australia, France, Netherlands
-
PfizerTerminatedAge-Related Macular DegenerationUnited States, United Kingdom, Australia, Netherlands
-
Novartis PharmaceuticalsCompletedDiabetic Macular Edema | Retinal Vein Occlusion | Wet Age Related Macular Degeneration | Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionSpain, China, Colombia, Korea, Republic of, Belgium, Greece, Japan, Russian Federation, Turkey, United Kingdom, Egypt, Germany, Australia, Canada, France, Austria, Hong Kong, Hungary, Israel, Netherlands, Peru, Singapore, Slovakia, Sl... and more
-
Novartis PharmaceuticalsCompletedAge-related Macular DegenerationUnited States, Austria, Czechia, Italy, Taiwan, Belgium, Germany, Australia, Israel, Canada, France, Spain, Korea, Republic of, United Kingdom, Portugal, Netherlands, Sweden, Argentina, Malaysia, Switzerland
-
NovartisCompletedSubfoveal Choroidal Neovascularization (CNV) | Secondary to Age-related Macular Degeneration (AMD)Germany, Belgium, Spain, Netherlands, United Kingdom, Hungary, Turkey, Israel, Portugal, Australia
-
Apellis Pharmaceuticals, Inc.Active, not recruitingGeographic Atrophy Secondary to Age-related Macular DegenerationUnited States, Netherlands, France, Israel, Germany, United Kingdom, Canada, Czechia, Australia, Spain, Italy, Argentina, Brazil, New Zealand, Poland
-
Apellis Pharmaceuticals, Inc.CompletedGeographic AtrophyUnited States, France, Italy, Netherlands, Israel, Germany, United Kingdom, Spain, Australia, New Zealand, Poland, Brazil, Canada, Czechia
-
Hoffmann-La RocheTerminatedGeographic AtrophyCanada, United States, Belgium, Peru, Argentina, Australia, Austria, Denmark, France, Germany, Hungary, Italy, Mexico, Netherlands, Poland, Slovakia, Spain, Switzerland, United Kingdom
-
Hoffmann-La RocheTerminatedGeographic AtrophyUnited States, United Kingdom, Netherlands, Germany, Belgium, Poland, Spain, Argentina, Australia, Hungary, Italy, Portugal, France, Turkey, Austria, Russian Federation, Mexico, Peru, Denmark, Slovakia, Sweden, Switzerland
-
Ural State Medical UniversityUral Institute of Cardiology; De Haar Research FoundationTerminatedCoronary Artery Disease | Cerebrovascular Disorders | Age-related Macular DegenerationNetherlands, Russian Federation
-
Hoffmann-La RocheTerminatedGeographic AtrophyUnited States, United Kingdom, Germany, France, Turkey, Australia, Austria, Belgium, Canada, Denmark, Hungary, Italy, Poland, Slovakia, Spain, Switzerland, Portugal, Netherlands, Peru
-
Prof. dr. R.O. SchlingemannRadboud University Medical Center; University Medical Center Groningen; UMC Utrecht and other collaboratorsUnknownDiabetic Macular EdemaNetherlands
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsActive, not recruitingMacular Degeneration | Retinal Degeneration | Geographic Atrophy | Dry Age-related Macular Degeneration | Retinal Disease | Macular AtrophyUnited States, Spain, United Kingdom, France, Germany, Australia, Netherlands, Poland
-
BayerCompletedOphthalmology, Macular DegenerationJapan, France, Germany, Australia, Italy, United Kingdom, Venezuela, Ireland, Netherlands, Canada
-
ThromboGenicsCompletedDiabetic Macular EdemaSpain, Belgium, United Kingdom, Italy, Netherlands, Germany
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentUnknown
-
ThromboGenicsCompletedEye Diseases | Vitreomacular Traction MaculopathyBelgium, Netherlands
-
Wageningen UniversityZonMw: The Netherlands Organisation for Health Research and Development; Wageningen...CompletedInflammation | Atherosclerosis | Hearing Loss | Cognitive Decline | Vascular Disease | Age-Related Memory DisorderNetherlands
-
Maastricht University Medical CenterEuropean Society of Cataract and Refractive SurgeonsCompletedDiabetes Mellitus | Cataract | Cystoid Macular EdemaNetherlands, Austria, Belgium, Germany, Hungary, Portugal, Spain
-
GlaxoSmithKlineCompletedRetinopathy, DiabeticAustralia, Netherlands, Italy, Germany, Denmark
-
Luigi RondasEuropean Society of Cataract and Refractive SurgeonsRecruitingEye Diseases | Macular Edema | Cataract | Lens Diseases | Retinal Disease | Cystoid Macular EdemaNetherlands, Austria, Germany, Portugal
-
AllerganCompletedMacular EdemaFrance, Spain, Belgium, United States, South Africa, Denmark, Netherlands, Israel, Portugal, United Kingdom, Italy, Germany
-
Lexicon PharmaceuticalsCompletedAge-Related Memory DisordersNetherlands
-
Abbott ProductsCompletedDiabetic Macular EdemaBulgaria, Czech Republic, Denmark, Germany, Hungary, Italy, Netherlands, Poland, Spain, United Kingdom
-
Allergan MedicalCompletedAge-related Volume Deficit in the Mid-faceBelgium, Netherlands, Germany, United Kingdom
-
PfizerCompletedMacular Edema Associated With Diabetes MellitusUnited States, Colombia, Australia, Germany, Italy, South Africa, Greece, France, Austria, United Kingdom, Denmark, India, Portugal, Brazil, Canada, Czechia, Netherlands, Switzerland
-
Pixium Vision SAActive, not recruitingGeographic AtrophyGermany, France, Italy, Netherlands, Spain, United Kingdom
-
Chromaderm, Inc.CompletedDiabetic RetinopathyUnited States, Canada, France, Denmark, Australia, Netherlands, Taiwan, Spain, Italy, Germany, Portugal, United Kingdom, Russian Federation, Poland, India, Brazil, Mexico
-
Hoffmann-La RocheCompletedWet Macular DegenerationUnited Kingdom, Germany, Japan, Netherlands, United States, Canada, Hungary, Italy, Mexico, Poland, Spain, Israel, Russian Federation, Switzerland, Turkey
-
NovartisCompletedDiabetic Macular EdemaGreece, Belgium, Spain, France, Netherlands, Australia, Canada, Germany, Hungary, Italy, Switzerland, Turkey, United Kingdom
-
Hoffmann-La RocheRecruitingUveitic Macular EdemaUnited States, Korea, Republic of, United Kingdom, China, Netherlands, Canada, Israel, Austria, Brazil, Italy, Taiwan, Poland, Portugal, Mexico
-
Sint Franciscus GasthuisCompletedAtherosclerosis | Oxidative Stress | Leukocyte Activation DisorderNetherlands
-
Novartis PharmaceuticalsCompletedMacular Edema (ME)Russian Federation, Turkey, United Kingdom, Belgium, Australia, Hungary, Switzerland, Germany, Italy, Korea, Republic of, Israel, Spain, France, Latvia, Netherlands, Slovakia, Czech Republic, Singapore, Canada
-
Radboud University Medical CenterUnknownInflammation | Hypertension | Dyslipidemias | Oxidative Stress | VasodilationNetherlands